Free tool
Stocks listed on Nasdaq GS
We cover 137 companies listed on Nasdaq GS. The median market value in the group is $679.77M. Across the group, the median move over the past trading day is −0.57%. 62% of the 130 with a 200-day average trade above it. Price change over the past year runs from −39.4% to +149.8% across the middle 80 percent of the group, with a median of +17.4%. Across the group, 1 company currently carries a tier A volume signal.
Other lists in this group
Table
137 of 1,279 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| PGNY | Progyny, Inc. | $1.98B | Small cap | +14.55% | Nov 5, 2026 |
| TSHA | Taysha Gene Therapies, Inc. | $1.96B | Small cap | +102.69% | Nov 4, 2026 |
| IMCR | Immunocore Holdings plc | $1.93B | Small cap | +13.69% | Nov 5, 2026 |
| LKFT | Lakefront Biotherapeutics NV | $1.91B | Small cap | −11.39% | Nov 12, 2026 |
| VIR | Vir Biotechnology, Inc. | $1.87B | Small cap | +111.85% | Nov 4, 2026 |
| RXRX | Recursion Pharmaceuticals, Inc. | $1.87B | Small cap | −28.63% | Nov 4, 2026 |
| SGRY | Surgery Partners, Inc. | $1.84B | Small cap | −38.48% | Nov 9, 2026 |
| INBX | Inhibrx Biosciences, Inc. | $1.81B | Small cap | +357.45% | Nov 13, 2026 |
| SNDX | Syndax Pharmaceuticals, Inc. | $1.77B | Small cap | +23.55% | Nov 2, 2026 |
| FTRE | Fortrea Holdings Inc. | $1.76B | Small cap | +105.20% | Nov 5, 2026 |
| AVLN | Avalyn Pharma Inc. | $1.64B | Small cap | +25.60% | Nov 16, 2026 |
| XERS | Xeris Biopharma Holdings, Inc. | $1.58B | Small cap | +8.64% | Nov 5, 2026 |
| ABSI | Absci Corporation | $1.58B | Small cap | +261.57% | Nov 16, 2026 |
| TRAX | First Tracks Biotherapeutics, Inc. | $1.58B | Small cap | +132.58% | Nov 5, 2026 |
| HCSG | Healthcare Services Group, Inc. | $1.57B | Small cap | +47.05% | Oct 21, 2026 |
| TYRA | Tyra Biosciences, Inc. | $1.56B | Small cap | +103.57% | Nov 4, 2026 |
| KMTS | Kestra Medical Technologies, Ltd. | $1.56B | Small cap | +47.61% | Sep 14, 2026 |
| INVA | Innoviva, Inc. | $1.53B | Small cap | +7.06% | Nov 4, 2026 |
| OMCL | Omnicell, Inc. | $1.53B | Small cap | +0.66% | Oct 29, 2026 |
| NVAX | Novavax, Inc. | $1.52B | Small cap | +21.50% | Nov 5, 2026 |
| REPL | Replimune Group, Inc. | $1.50B | Small cap | +187.16% | Nov 5, 2026 |
| INNV | InnovAge Holding Corp. | $1.48B | Small cap | +178.79% | Sep 8, 2026 |
| CGEM | Cullinan Therapeutics, Inc. | $1.48B | Small cap | +188.15% | Nov 5, 2026 |
| AKTS | Aktis Oncology, Inc. | $1.47B | Small cap | +18.35% | Nov 12, 2026 |
| AZTA | Azenta, Inc. | $1.47B | Small cap | +11.16% | Nov 20, 2026 |
| OMDA | Omada Health, Inc. | $1.47B | Small cap | +2.74% | Nov 5, 2026 |
| SDGR | Schrödinger, Inc. | $1.46B | Small cap | −1.62% | Nov 4, 2026 |
| ATEC | Alphatec Holdings, Inc. | $1.45B | Small cap | −41.78% | Oct 29, 2026 |
| ORIC | ORIC Pharmaceuticals, Inc. | $1.44B | Small cap | +35.58% | Nov 12, 2026 |
| MGTX | MeiraGTx Holdings plc | $1.43B | Small cap | +100.54% | Nov 12, 2026 |
| PNTG | The Pennant Group, Inc. | $1.34B | Small cap | +56.31% | Nov 4, 2026 |
| IART | Integra LifeSciences Holdings Corporation | $1.31B | Small cap | +13.52% | Oct 29, 2026 |
| VOR | Vor Biopharma Inc. | $1.30B | Small cap | −40.82% | Nov 12, 2026 |
| SANA | Sana Biotechnology, Inc. | $1.25B | Small cap | +23.44% | Nov 5, 2026 |
| GDRX | GoodRx Holdings, Inc. | $1.25B | Small cap | −18.89% | Nov 3, 2026 |
| CERT | Certara, Inc. | $1.24B | Small cap | −25.07% | Nov 5, 2026 |
| GLUE | Monte Rosa Therapeutics, Inc. | $1.23B | Small cap | +207.92% | Nov 5, 2026 |
| KURA | Kura Oncology, Inc. | $1.16B | Small cap | +66.16% | Nov 3, 2026 |
| SVRA | Savara Inc. | $1.15B | Small cap | +70.52% | Nov 11, 2026 |
| LMRI | Lumexa Imaging Holdings, Inc. | $1.15B | Small cap | −35.42% | Nov 12, 2026 |
| OPK | OPKO Health, Inc. | $1.11B | Small cap | +6.34% | Oct 28, 2026 |
| SLDB | Solid Biosciences Inc. | $1.04B | Small cap | +72.95% | Nov 2, 2026 |
| ABUS | Arbutus Biopharma Corporation | $1.03B | Small cap | +42.19% | Nov 16, 2026 |
| QDEL | QuidelOrtho Corporation | $1.02B | Small cap | −46.31% | Nov 5, 2026 |
| PCRX | Pacira BioSciences, Inc. | $1.02B | Small cap | −0.88% | Nov 5, 2026 |
| GERN | Geron Corporation | $995.83M | Small cap | +8.51% | Nov 4, 2026 |
| DSGN | Design Therapeutics, Inc. | $975.65M | Small cap | +194.71% | Nov 5, 2026 |
| BVS | Bioventus Inc. | $954.22M | Small cap | +86.52% | Nov 3, 2026 |
| OLMA | Olema Pharmaceuticals, Inc. | $949.35M | Small cap | +89.02% | Nov 9, 2026 |
| ANNX | Annexon, Inc. | $946.00M | Small cap | +136.49% | Nov 9, 2026 |
| AMPH | Amphastar Pharmaceuticals, Inc. | $934.98M | Small cap | −27.78% | Nov 5, 2026 |
| ACRS | Aclaris Therapeutics, Inc. | $911.16M | Small cap | +240.11% | Nov 5, 2026 |
| CBLL | CeriBell, Inc. | $899.97M | Small cap | +102.16% | Nov 3, 2026 |
| SGP | SpyGlass Pharma, Inc. | $891.05M | Small cap | +0.91% | Nov 5, 2026 |
| RIGL | Rigel Pharmaceuticals, Inc. | $864.97M | Small cap | +16.99% | Nov 3, 2026 |
| INMD | InMode Ltd. | $864.89M | Small cap | −1.71% | Nov 4, 2026 |
| FDMT | 4D Molecular Therapeutics, Inc. | $859.60M | Small cap | +140.87% | Nov 10, 2026 |
| COLL | Collegium Pharmaceutical, Inc. | $852.79M | Small cap | −29.08% | Nov 5, 2026 |
| HSTM | HealthStream, Inc. | $840.94M | Small cap | +1.86% | Nov 2, 2026 |
| STTK | Shattuck Labs, Inc. | $792.87M | Small cap | +690.00% | Nov 12, 2026 |
| VREX | Varex Imaging Corporation | $778.90M | Small cap | +61.40% | Nov 17, 2026 |
| SOPH | SOPHiA GENETICS SA | $726.14M | Small cap | +156.16% | Nov 3, 2026 |
| CTMX | CytomX Therapeutics, Inc. | $723.43M | Small cap | +60.39% | Nov 5, 2026 |
| PHAT | Phathom Pharmaceuticals, Inc. | $709.50M | Small cap | −29.50% | Oct 29, 2026 |
| IRWD | Ironwood Pharmaceuticals, Inc. | $708.88M | Small cap | +240.48% | Nov 9, 2026 |
| ALLO | Allogene Therapeutics, Inc. | $704.80M | Small cap | +75.86% | Nov 5, 2026 |
| ZVRA | Zevra Therapeutics, Inc. | $697.17M | Small cap | +25.43% | Nov 4, 2026 |
| EVO | Evotec SE | $693.01M | Small cap | −44.13% | Nov 5, 2026 |
| EIKN | Eikon Therapeutics, Inc. | $679.77M | Small cap | −20.13% | Nov 12, 2026 |
| ANGO | AngioDynamics, Inc. | $648.51M | Small cap | +56.74% | Oct 1, 2026 |
| CTNM | Contineum Therapeutics, Inc. | $640.31M | Small cap | +70.03% | Oct 29, 2026 |
| TLRY | Tilray Brands, Inc. | $638.38M | Small cap | −66.13% | Oct 8, 2026 |
| AUTL | Autolus Therapeutics plc | $620.16M | Small cap | +48.41% | Nov 16, 2026 |
| ARVN | Arvinas, Inc. | $609.40M | Small cap | +15.35% | Nov 4, 2026 |
| MPLT | MapLight Therapeutics, Inc. | $596.42M | Small cap | −29.88% | Nov 12, 2026 |
| CTKB | Cytek Biosciences, Inc. | $594.02M | Small cap | +11.74% | Nov 4, 2026 |
| RGNX | REGENXBIO Inc. | $588.18M | Small cap | +6.35% | Nov 5, 2026 |
| KYTX | Kyverna Therapeutics, Inc. | $546.70M | Small cap | +133.33% | Nov 11, 2026 |
| CABA | Cabaletta Bio, Inc. | $545.94M | Small cap | +116.67% | Nov 16, 2026 |
| PRLD | Prelude Therapeutics Incorporated | $522.47M | Small cap | +412.50% | Nov 11, 2026 |
| CCCC | C4 Therapeutics, Inc. | $521.63M | Small cap | +64.34% | Nov 5, 2026 |
| SENS | Senseonics Holdings, Inc. | $493.84M | Small cap | +0.43% | Nov 4, 2026 |
| CGC | Canopy Growth Corporation | $492.21M | Small cap | −31.46% | Nov 6, 2026 |
| EDIT | Editas Medicine, Inc. | $488.38M | Small cap | +19.10% | Nov 9, 2026 |
| NRC | NRC Health | $487.06M | Small cap | +45.92% | Oct 26, 2026 |
| PACB | Pacific Biosciences of California, Inc. | $484.90M | Small cap | +17.29% | Nov 5, 2026 |
| KMDA | Kamada Ltd. Ordinary Shares | $483.48M | Small cap | +21.09% | Nov 9, 2026 |
| CAPR | Capricor Therapeutics, Inc. | $481.97M | Small cap | +49.76% | Nov 10, 2026 |
| PRTA | Prothena Corporation plc | $474.87M | Small cap | +8.06% | Nov 5, 2026 |
| PBYI | Puma Biotechnology, Inc. | $472.84M | Small cap | +79.61% | Nov 5, 2026 |
| SGHT | Sight Sciences, Inc. | $458.33M | Small cap | +97.87% | Nov 5, 2026 |
| BIOA | BioAge Labs, Inc. | $451.63M | Small cap | +107.59% | Nov 5, 2026 |
| AVIR | Atea Pharmaceuticals, Inc. | $441.93M | Small cap | +53.06% | Nov 11, 2026 |
| CARL | Carlsmed, Inc. | $441.76M | Small cap | +16.40% | Nov 5, 2026 |
| ENTA | Enanta Pharmaceuticals, Inc. | $412.12M | Small cap | +65.89% | Nov 16, 2026 |
| OFIX | Orthofix Medical Inc. | $397.14M | Small cap | −34.30% | Nov 3, 2026 |
| UPB | Upstream Bio, Inc. | $390.52M | Small cap | −57.31% | Nov 4, 2026 |
| MOBI | Mobia Medical, Inc. | $387.35M | Small cap | −0.85% | Nov 9, 2026 |
| SLP | Simulations Plus, Inc. | $372.34M | Small cap | +28.20% | Oct 29, 2026 |
| LYEL | Lyell Immunopharma, Inc. | $362.68M | Small cap | +37.32% | Nov 6, 2026 |
| IFRX | InflaRx N.V. | $356.63M | Small cap | +142.00% | Nov 9, 2026 |
| TMCI | Treace Medical Concepts, Inc. | $306.96M | Small cap | −36.39% | Nov 5, 2026 |
| BCYC | Bicycle Therapeutics plc | $304.03M | Small cap | −37.79% | Oct 29, 2026 |
| AVXL | Anavex Life Sciences Corp. | $300.34M | Small cap | −65.71% | Nov 24, 2026 |
| MYGN | Myriad Genetics, Inc. | $298.43M | Small cap | −47.39% | Nov 2, 2026 |
| NMRA | Neumora Therapeutics, Inc. | $293.12M | Small cap | −11.36% | Nov 5, 2026 |
| ANIK | Anika Therapeutics, Inc. | $290.14M | Small cap | +136.17% | Nov 4, 2026 |
| EMBC | Embecta Corp. | $285.00M | Small cap | −64.70% | Nov 25, 2026 |
| PYXS | Pyxis Oncology, Inc. | $278.58M | Small cap | +145.59% | Nov 2, 2026 |
| ALXO | ALX Oncology Holdings Inc. | $273.79M | Small cap | +65.00% | Nov 6, 2026 |
| ALEC | Alector, Inc. | $263.51M | Small cap | +2.50% | Nov 5, 2026 |
| MGNX | MacroGenics, Inc. Common Stock | $257.35M | Small cap | +134.88% | Nov 12, 2026 |
| OSUR | OraSure Technologies, Inc. | $255.87M | Small cap | +11.08% | Nov 4, 2026 |
| LAB | Standard BioTools Inc. | $255.18M | Small cap | −49.08% | Nov 3, 2026 |
| IPHA | Innate Pharma S.A. | $253.56M | Small cap | +2.86% | Sep 17, 2026 |
| PEPG | PepGen Inc. | $237.21M | Small cap | +159.68% | Nov 11, 2026 |
| TNXP | Tonix Pharmaceuticals Holding Corp. Common Stock | $233.94M | Small cap | −57.61% | Nov 9, 2026 |
| UTMD | Utah Medical Products, Inc. | $225.70M | Small cap | +17.76% | Oct 22, 2026 |
| SPOK | Spok Holdings, Inc. | $217.86M | Small cap | −36.39% | Oct 28, 2026 |
| ABOS | Acumen Pharmaceuticals, Inc. | $216.23M | Small cap | +115.11% | Nov 11, 2026 |
| VYGR | Voyager Therapeutics, Inc. | $213.20M | Small cap | +1.17% | Nov 9, 2026 |
| NKTX | Nkarta, Inc. | $194.10M | Small cap | +17.41% | Nov 10, 2026 |
| HUMA | Humacyte, Inc. | $189.35M | Small cap | −55.45% | Nov 12, 2026 |
| CDXS | Codexis, Inc. | $180.68M | Small cap | −38.20% | Nov 5, 2026 |
| LFCR | Lifecore Biomedical, Inc. | $176.02M | Small cap | −38.25% | Nov 3, 2026 |
| AARD | Aardvark Therapeutics, Inc. | $149.04M | Small cap | −24.25% | Nov 12, 2026 |
| INGN | Inogen, Inc. | $147.55M | Small cap | −29.89% | Nov 5, 2026 |
| MIST | Milestone Pharmaceuticals Inc. | $146.91M | Small cap | −33.33% | Nov 12, 2026 |
| LENZ | LENZ Therapeutics, Inc. | $146.73M | Small cap | −87.21% | Nov 4, 2026 |
| MXCT | MaxCyte, Inc. | $139.33M | Small cap | −6.43% | Nov 11, 2026 |
| BDTX | Black Diamond Therapeutics, Inc. | $130.42M | Small cap | −20.91% | Nov 5, 2026 |
| CPIX | Cumberland Pharmaceuticals Inc. | $130.35M | Small cap | +163.82% | Nov 3, 2026 |
| APYX | Apyx Medical Corporation | $128.48M | Small cap | +54.04% | Nov 5, 2026 |
| BMEA | Biomea Fusion, Inc. | $123.95M | Small cap | −8.06% | Nov 3, 2026 |
| HCAT | Health Catalyst, Inc. | $118.91M | Small cap | −56.91% | Nov 9, 2026 |
| SEER | Seer, Inc. | $112.96M | Small cap | −1.94% | Nov 5, 2026 |
| LUNG | Pulmonx Corporation | $105.59M | Small cap | +34.41% | Nov 11, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.